Podcasts about Rahul

Happy Tuesday, Everyone! This week, I sat down with my new friend Rahul Kohli to chat, while on a break from filming Mike Flanagan's new show Carrie. In addition to co-starring with me on the new project, Rahul has found so many new fans as a heartthrob in Mike's other recent shows, including playing Owen in The Haunting of Bly Manor, Sheriff Hassan in Midnight Mass and Leo Usher in The Fall of The House of Usher. You may also know him from his roles as Ravi Chakrabarti in iZombie and Bri in The Life of Chuck, as well as his prolific video game voice work. We had a lot of fun talking about how he fell in love with movies and video games, while growing up as a South Asian kid in the UK and he found his way as an actor without a well-worn path to follow. This conversation really feels like two friends sitting down for coffee, getting real about the life of a working actor— from how to use social media, to embracing insecurity and learning to let go and trust your director. I feel much closer to Rahul after this conversation, and I think you will too! Be sure to stick around after our chat for the Hindsight, where my producer Jeph and I talk about the episode, share details about upcoming live shows and vent about an airplane nemesis! Send me an email thesackhoffshow@gmail.com Produced by Rabbit Grin Productions Mail Sack Song by Nicolas @producer_sniffles Join us on Patreon! http://patreon.com/thesackhoffshow ----------------------------------------------------- Support our Sponsors: Try Mint Mobile's Unlimited Wireless Plan for only $15/mo for three months at MintMobile.com/SACKHOFF Save 20% Off Honeylove by going to honeylove.com/SACKHOFF! #honeylovepod Get 15% off OneSkin with the code SACKHOFF at https://www.oneskin.co/  #oneskinpod

Some conversations change lives. Others change the way we think about how we have them.In this episode, I share the lesson I took from Dr. Rahul Jandial, world-renowned brain surgeon, neuroscientist, and author, about the quiet power of the pause.Rahul has delivered some of the hardest news anyone can hear. And what he's learned is that it's not just the words that matter, it's what happens after them. In those seconds of silence, people begin to process, to find their footing, to summon the courage for what comes next.It's a habit we can all use. At work when we're giving feedback. At home in tough conversations. In moments with friends when they trust us enough to share what's really going on.In this episode, we explore:How silence builds trust faster than reassuranceThe neuroscience behind giving people space to thinkWhy the pause can change the way we lead, comfort, and connectHow to practice it in your everyday lifeIf you've ever wanted to show up better in the conversations that matter most, this one's for you.Here is more information on the studies referenced: Physician–Patient Communication: The Relationship With Malpractice Claims (Wendy Levinson et al., JAMA 1997)How to Stop Saying “Um,” “Ah,” and “You Know” Harvard Business ReviewListen to the full episode with Dr. Rahul Jandial: https://pod.fo/e/251425

Welcome to the Oncology Brothers podcast! In this episode, we continue our hematology series by diving deep into myelofibrosis (MF) with Dr. Raajit Rampal, an expert in myeloproliferative neoplasms from the Memorial Sloan Kettering Cancer Center. Join Drs. Rahul and Rohit Gosain as they discuss the latest updates in symptom management, emerging treatment combinations, and the importance of timely diagnosis and risk stratification for patients presenting with cytopenias and splenomegaly. Key topics covered in this episode include: • The initial workup and diagnostic criteria for myelofibrosis • The role of next-generation sequencing and bone marrow biopsy • Risk stratification using the IPSS and DIPSS scoring systems • First-line treatment options, including the four available JAK inhibitors: Ruxolitinib, Momelotinib, Fedratinib, and Pacritinib • Supportive care strategies for managing anemia and thrombocytopenia • The importance of clinical trials and early referral for transplant Tune in to gain valuable insights into the evolving treatment landscape for myelofibrosis and learn how community oncologists can effectively manage this complex disease. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more episodes in our hematology series and check out our previous discussions!

Welcome back to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by world-renowned medical oncologist Dr. Monty Pal from the City of Hope. Together, they dived deep into the management of side effects associated with tyrosine kinase inhibitors (TKIs) and HIF-2 alpha inhibitors used in treating renal cell carcinoma (RCC). Episode Highlights: • Understanding TKIs and HIF-2 Inhibitors: A discussion on the available oral treatment options for RCC, including cabozantinib, lenvatinib, and axitinib. • Dosing Strategies: Insights on starting doses, titration, and the importance of managing side effects without compromising quality of life. • Common Side Effects: hypertension, diarrhea, fatigue, and how they relate to the class effect of these medications. • Clinical Pearls: Dr. Pal shared valuable tips on managing toxicities, including the use of treatment breaks and supportive care strategies. • Second-Line Treatments: A look at tivozanib and belzutifan, including their unique side effects and management strategies. Join us as we emphasized the importance of maintaining quality of life for patients undergoing treatment for metastatic RCC.  Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to check out our other episodes for more insights on treatment algorithms, conference highlights, and challenging cases from the community.

Modi is Planning Big Actions? | 5th Aug No Ball | Rahul vs SC | Next Vice President? | Harsh Kumar

Modi is Planning Big Actions? | 5th Aug No Ball | Rahul vs SC | Next Vice President? | Harsh Kumar

In this episode of the Oncology Brothers podcast, Drs. Rahul and Rohit Gosain dived deep into the world of myeloproliferative neoplasms (MPNs), focusing specifically on polycythemia vera (PV) and essential thrombocythemia (ET). They are joined by Dr. Andrew Kuykendall, a hematologist from Moffitt Cancer Center, who shared his expertise on the latest treatment paradigms and risk stratification strategies for these conditions. Key topics discussed included: • The importance of ruling out secondary causes of erythrocytosis in PV patients. • The role of JAK2 mutation testing and EPO levels in diagnosis of PV. • Treatment options for PV, including phlebotomy, hydroxyurea, and interferon, as well as the emerging role of ruxolitinib. • Risk stratification in ET and the significance of driver mutations like JAK2, CALR, and MPL. • The management of acquired von Willebrand disease in patients with high platelet counts. • Insights from Dr. Kuykendall's recent ASCO plenary presentation on the VERIFY Study and the potential of resveratide in PV treatment. Join us for an informative discussion that highlights the evolving landscape of MPN management and the importance of individualized treatment plans.  Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to check out our other hematology episodes for more insights into challenging cases and treatment algorithms!  

Coming Soon: End of Sonia-Rahul-Priyanka Era in Congress? | Modi Trump Impact |Bihar |AbhishekTiwari

This is episode 438 of the Mobile Tech Podcast with guests Rahul Sandil (MediaTek) and Jason Howell (Android Faithful) -- brought to you by MediaTek. This episode comes in two parts. First, we explore MediaTek's AI strategy and how AI is changing the way we interact with our devices. Second (19:43), we review Samsung's Galaxy Z Fold7 and Z Flip7, then discuss the latest Galaxy, Pixel, and iPhone leaks and rumors. Finally, we cover WPC's Qi2 25W, Realme's 15 series, and other mobile tech news.Episode Links- Support the podcast on Patreon: https://www.patreon.com/tnkgrl- Donate / buy me a coffee (PayPal): https://tnkgrl.com/tnkgrl/- MediaTek: http://www.poweredbymediatek.com/ (sponsor)- MediaTek's AI strategy: https://www.mediatek.com/technology/ai- Rahul Sandil: https://www.linkedin.com/in/rahulsandil/- Jason Howell: https://www.threads.net/@thatjasonhowell- Samsung's Galaxy Z Fold7 review: https://www.androidfaithful.com/episode/all-the-dirt-on-the-z-fold-7-android-faithful-episode-105/- Samsung's Galaxy Z Flip7 review: https://www.tomsguide.com/phones/samsung-phones/samsung-galaxy-z-flip-7-hands-on-review-feels-like-flip-phone-perfection- Samsung Galaxy S26 Pro rumors: https://www.gsmarena.com/samsung_galaxy_s26s_replacement_seemingly_confirmed-news-68831.php- Google Pixel 10 series pricing leaks: https://www.gsmarena.com/google_pixel_10_familys_prices_in_the_us_and_canada_leak-news-68832.php- WPC Qi2 25W: https://9to5google.com/2025/07/23/qi2-25w-charging-speed-android-smartphones/- Apple iPhone 17 series colors leak: https://www.gsmarena.com/iphone_17_dummies_pose_with_their_updated_color_palettes-news-68824.php- Realme 15 series: https://www.gsmarena.com/realme_15_and15_pro_debut_with_more_powerful_chipsets_and_new_camearas-news-68754.phpAffiliate Links (If you use these links to buy something, we might earn a commission)- Samsung Galaxy Z Fold7: https://amzn.to/3IGlReM- Samsung Galaxy Z Flip7: https://amzn.to/3IoaGHD- Samsung Galaxy S25 Edge: https://amzn.to/43et2TD- Google Pixel 9a: https://amzn.to/3SV8fOR- Nothing Phone (3): https://amzn.to/45bPRYK

* அதானிக்கு உதவுவதற்காக பாஜக பொருளாதாரத்தை அழித்துவிட்டது - ராகுல்.•⁠ ⁠அமெரிக்க வரி விதிப்பு: மத்திய அரசு தீவிர ஆலோசனை?•⁠ ⁠ஈரானுடன் வர்த்தகம் 6 இந்திய நிறுவங்களுக்கு தடை?•⁠ ⁠"உங்களை யாராவது மதம் மாற்றினார்களா?" -பாஜகவினரிடம் எம்.பி. ஜான் பிரிட்டாஸ் கேள்வி•⁠ ⁠UAPA: கைதானது 6,500... தண்டனை பெற்றதோ 250?•⁠ ⁠அமித் ஷா & ஜெய்சங்கரை பாராட்டிய மோடி?•⁠ ⁠மாலேகான் குண்டுவெடிப்பு: `இது நீதியே அல்ல' - BJP Ex எம்.பி உட்பட 7 பேர் விடுதலையை எதிர்க்கும் ஒவைசி•⁠ ⁠மக்களிடம் ஐடியா கேட்கும் பிரதமர் மோடி?•⁠ ⁠குடியரசு துணைத் தலைவர் தேர்தல் எப்போது?•⁠ ⁠டாக்டர் எம்.எஸ்.சுவாமிநாதன் பெயரில் உணவு, அமைதிக்கான சர்வதேச விருது?•⁠ ⁠சட்டமன்றத்திற்குள் ரம்மி விளையாடிய அமைச்சருக்கு விளையாட்டுத் துறை ஒப்படைப்பு!•⁠ ⁠பிரஜ்வல் ரேவண்ணா குற்றவாளி என தீர்ப்பு!•⁠ ⁠OPS: "தேர்தல் நெருங்குகின்ற நேரத்தில் எதுவும் நடக்கலாம்"-மு.க.ஸ்டாலின் சந்திப்புக் குறித்து ஓ.பி.எஸ் •⁠ ⁠முதலமைச்சர் மு.க.ஸ்டாலினை சந்தித்து நலம் விசாரித்த மதிமுக பொதுச்செயலாளர் வைகோ!•⁠ ⁠`பிரதமரை சந்திக்க நான் ஏற்பாடு பண்றேன்...' - ஓபிஎஸ்ஸுக்கு தூதுவிடும் நயினார்?•⁠ ⁠'நலம் காக்கும் ஸ்டாலின்' திட்டம் மூலம் மொத்தம் 1,256 முகாம்கள் நடத்தப்படவுள்ளன - ராதாகிருஷ்ணன்.•⁠ ⁠முதலமைச்சரை சந்திக்க உள்ளதாக பரவிய தகவலுக்கு ராமதாஸ் மறுப்பு•⁠ ⁠அதிமுக பொதுச்செயலாளராக தேர்வானதை எதிர்த்த வழக்கை நிராகரிக்கக் கோரிய இபிஎஸ் மனு தள்ளுபடி•⁠ ⁠ஆணவக் கொலை செய்யப்பட்ட கவினின் உடல் பெற்றோரிடம் ஒப்படைப்பு •⁠ ⁠நெல்லை: ”விரைவில் ஆணவக் கொலைக்கு எதிரான சட்டம் நிறைவேற்றப்படும் என நம்புகிறோம்” – கனிமொழி MP •⁠ ⁠"சுர்ஜித்தின் அம்மாவை கைதுசெய்ய வேண்டும்" - கவின் தந்தை வலியுறுத்தல்•⁠ ⁠பாலத்தீன அரசை அங்கீகரிக்க பிரிட்டன், பிரான்ஸை தொடர்ந்து கனடாவும் முடிவு•⁠ ⁠சவுதி அரேபியா: ராட்சத ராட்டினம் இரண்டாக உடைந்து விபத்து: 26 பேர் படுகாயம் - பதறவைக்கும் வீடியோ!

Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain, practicing community oncologists, share their key takeaways from a session on NTRK Fusion Positive Solid Malignancies, they moderated during a satellite event at ASCO 2025 in partnership with Medscape Global Oncology. Join us as we discuss: •⁠  ⁠The prevalence of NTRK fusions in various cancers and why community oncologists should be aware of them. •⁠  ⁠The importance of comprehensive next-generation sequencing (NGS) for detecting these fusions across diverse histologies. •⁠  ⁠Available treatment options, including first-generation NTRK inhibitors like larotrectinib and entrectinib, and their efficacy in improving overall and progression-free survival. •⁠  ⁠Insights into the CNS activity of these treatments and the common side effects patients may experience. •⁠  ⁠Special considerations for pediatric patients, including formulation challenges and the potential for re-challenging with NTRK inhibitors. Don't forget to check out the full accredited enduring program by Medscape Global Oncology linked below, and earn your CME credit.  https://www.medscape.org/viewarticle/1002679?src=acdmpart_onc-brothers_1002679  Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ #entrectinib #larotrectinib #repotrectinib

Awesome Modi & Amit Shah in Parliament | Rahul, Priyanka Red Faced | Harsh Kumar, Sanjay Dixit

In this episode of ELI, we welcome Rahul Mehra, the co-founder of Roadcast, a SaaS platform specializing in fleet management and tracking. Rahul shares his entrepreneurial journey, from his early days as a marketer at Ogilvy to building a successful tech company. He discusses the evolution of Roadcast, its pivots, and its impact on various industries, including logistics, construction, and even law enforcement with the Delhi Police. Rahul also delves into the role of AI in their technology and their future vision of making Roadcast a household name.Chapters**00:00 – Introduction: Welcoming Rahul Mehra, Co-Founder of Roadcast**- Host introduces the format and today's guest, Rahul Mehra, who cofounded Roadcast, a leading SaaS platform for fleet management and tracking.**00:35 – About Roadcast: The Tracking Company**- Rahul shares Roadcast's core business concept, pivots, and its unwavering focus on tracking technology.**01:13 – Early Journey: From Delhi to Entrepreneurship**- Rahul talks about his upbringing in Delhi, his schooling, and initial career aspirations influenced by family expectations.**03:06 – Creative Passions and Early Ventures**- Balancing engineering with web design, music, and even DJing. How these creative skills contributed to his first business, First Look Media.**04:51 – Industry Experience: Digital Agencies & Ogilvy**- Rahul's industry exposure starts with a digital agency internship, then a leap to Ogilvy as one of the youngest art directors, and facing the reality of formal education alongside work.**07:25 – Finishing Engineering & Career Dilemma**- Taking a sabbatical from Ogilvy to (miraculously) finish his engineering degree, and pondering future career steps.**08:03 – The Spark: Roadcast's Origin Story**- How a casual call with his co-founders about solving group travel coordination led to creating the first version of Roadcast.**09:36 – The First Product: Social Location Tracking App**- Building an early real-time location sharing app (before WhatsApp had live location) and challenges of launching a social product from India.**10:12 – The First Pivot: From B2C to B2B**- Advice from early advisor Deepak Jain leads Roadcast to focus on logistics and delivery tracking for businesses instead of consumers.**11:22 – Building the Technology: In-house vs Outsourcing**- Decision between outsourcing the MVP and eventually building apps in-house, including structuring the founding team.**13:40 – First Customer and Initial Success**- Winning the first customer (Brookfield) in highway management, then rapid expansion into restaurant delivery logistics.**14:57 – The Restaurant Boom & Second Major Pivot**- Scaling fast with restaurant chains, but the industry shifts when Zomato/Swiggy take over deliveries. Roadcast pivots to hardware (IoT/vehicle) tracking.**16:50 – Tech Evolution: From GPS to AI Dashcams**- Advancements in tracking: modern sensors, dashcams, AI-based driver behavior monitoring, and expanding hardware capabilities.**18:05 – Use Cases & Industrial Adoption**- Overview of industry coverage, from logistics, construction, and EVs, to taxis—how their platform adapts across sectors.**21:02 – Business Model & Government Clients**- Subscription pricing, hardware/software model, and case study on long-term collaboration with Delhi Police.**23:08 – Real-World Impact: ROI for Clients**- Concrete examples of customer cost savings: route/fleet optimization, fuel theft reduction, safety benefits, quick payback periods for businesses.**24:44 – The Next Leap: Launching “Track What Matters” B2C Expansion**- Introducing a new consumer line (devices for pets, kids, personal safety), aiming for Roadcast to become a household name.**25:49 – Consumer Products: Safety Devices & Pet Trackers**- Details about the product range: kid-safe devices, pet GPS trackers, female safety gadgets, and dash cams.

In this episode of Inside SAP S/4HANA Cloud, host Yannick Peterschmitt welcomes Rahul Bhardwaj from dsm-firmenich to share his remarkable ERP transformation journey. From unexpected surprises during onboarding to leading a pioneering Public Cloud implementation, Rahul discusses the importance of asking "why," embracing a cloud mindset, and navigating change management. Discover how his team turned a business challenge into an award-winning innovation—and why pickleball perfectly describes his SAP journey.

•⁠ ⁠மக்களவையில் ராகுல் காந்தி அடுக்கடுக்கான கேள்விகள்!•⁠ ⁠பிரதமர் பதவியை வகிக்கும் தகுதி உங்களுக்கு இல்லை." - மல்லிகார்ஜுன கார்கே•⁠ ⁠மத்திய அரசைச் சாடிய பிரியங்கா காந்தி!•⁠ ⁠“பஹல்காம் தாக்குதல் முழுக்க முழுக்க உளவுத்துறையின் தோல்வியே” - ஆ.ராசா விமர்சனம்•⁠ ⁠``நேருவை இளைஞர்களிடம் கொண்டு சேர்ப்பதற்கு நன்றி!'' - கனிமொழி•⁠ ⁠“நாடாளுமன்றத்தில் ஜனநாயகமே இல்லாமல் போய்விட்டது” - மாநிலங்களவையில் திமுக எம்.பி., திருச்சி சிவா பேச்சு •⁠ ⁠என்ன பேசினார் ப.சிதம்பரம்?•⁠ ⁠மோடியை தாக்கும் சுப்பிரமணியன் சுவாமி?•⁠ ⁠தேஜஸ்வி சூர்யா பேசும்போது இருக்கையை பிடிக்க முந்திய பா.ஜ.க எம்.பிக்கள்!•⁠ ⁠Modi: "பாகிஸ்தானின் விமான தளங்கள் ICU-ல் இருக்கின்றன" - மக்களவையில் பிரதமரின் `நறுக்' வசனங்கள்! •⁠ ⁠எம். பி சு.வெ க்கு கொலை மிரட்டல்?•⁠ ⁠மோடி பேசியது வருத்தம் அளிக்கிறது - பஹல்காமில் உயிரிழந்தவரின் மனைவி பேட்டி •⁠ ⁠ஆக.26இல் மீண்டும் தமிழ்நாடு வருகிறார் பிரதமர் மோடி? •⁠ ⁠செப்டம்பரில் பாலஸ்தீனத்துக்கு அங்கீகாரம்? - பிரிட்டன் அறிவிப்பு•⁠ ⁠`இந்தியாவின் மீது 20 - 25 சதவிகித பரஸ்பர வரியா?' - ட்ரம்பின் பதில் என்ன? •⁠ ⁠ரஷ்யாவில் சக்திவாய்ந்த நிலநடுக்கம் பதிவு? •⁠ ⁠ரஷ்யா மற்றும் ஜப்பானை தாக்கிய சுனாமி அலைகள்? •⁠ ⁠மடப்புரம் அஜித் குடும்பத்திற்கு இபிஎஸ் ஆறுதல் •⁠ ⁠சி.பி.ஐ விசாரணைக்கு பின் நிகிதா சொன்னது என்ன?•⁠ ⁠பாஜக கூட்டணியில் நீடிப்பது குறித்து ஓபிஎஸ் இன்று முக்கிய முடிவு? •⁠ ⁠ஓடிபி கேட்காத வகையில் MYTVK செயலி•⁠ ⁠உதவி ஆய்வாளரை வெட்ட விரட்டிய 17 வயது சிறுவர்கள்.. சுட்டுப்பிடித்த போலீஸ்! அதிர்ச்சி பின்னணி •⁠ ⁠நெல்லை இளைஞர் கவின் ஆணவக் கொலை விவகாரம்: கி.வீரமணி கோரிக்கை •⁠ ⁠சொகுசு காரை ஏற்றி இளைஞரைக் கொன்ற திமுக பிரமுகரின் பேரன்?

RAHUL PATIL from Radio Tarana in Auckland previews the fifth and final Test abut to get underway at The Oval. After a very short break since Old Trafford, what can we expect and is the punishing schedule now taking its toll on all the players? Rahul also reports on the ICC AGM, which recently took place Singapore where he was representing the Cook Islands and provides some very interesting feedback.

Rahul Gandhi & Priyanka Gandhi Vadra led Opposition's charge during Op Sindoor debate in Lok Sabha while PM Modi and Amit Shah fronted govt defence. From Pahalgam attack to China-Pakistan ‘fusion', Operation Mahadev to Trump's role & US President's lunch with Munir— what are the big takeaways from the Op Sindoor debate in Lok Sabha? ThePrint Editor-In-Chief Shekhar Gupta explains: Ep xxxx of #CutTheClutter

RAHUL PATIL from Radio Tarana in Auckland previews the fish and final Test abut to get underway at The Oval. After a very short break since Old Trafford, what can we expect and is the punishing schedule now taking its toll on all the players? Rahul also reports on the ICC AGM, which recently took place Singapore where he was representing the Cook Islands and provides some very interesting feedback.

In this episode of the Oncology Brothers podcast, Drs. Rahul and Rohit Gosain dive into the complexities of relapsed refractory Acute Myeloid Leukemia (AML) with FLT3 mutations. Joined by leukemia specialists Dr. Uma Borate from the Ohio State University and Dr. Naval Daver from the MD Anderson Cancer Center, the discussion focused on real-life cases and the current standard of care for patients with FLT3-positive AML. Key topics included: •⁠  ⁠The importance of retesting for FLT3 mutations at the time of relapse •⁠  ⁠Treatment paradigms for fit vs. unfit patients •⁠  ⁠The role of Gilteritinib and combination therapies in relapsed settings •⁠  ⁠Management of side effects, including cytopenias and differentiation syndrome •⁠  ⁠Insights into the use of hypomethylating agents and the potential of oral therapies Whether you're a healthcare professional or someone interested in the latest advancements in cancer care, this episode provides valuable insights into the management of challenging AML cases. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more discussions on the latest in oncology!

England India Daily, 4th Test, Old Trafford Day 4: KL Rahul and Shubman Gill dug in after the series looked over when losing two immediate wickets in their second dig. Can they keep India's series hopes alive tomorrow? Ben Stokes scored a typically pugilistic century, but at what cost to his fitness? Will he be able to bowl tomorrow? With the series on the line, an intriguing Day 5 in Manchester awaits. Daniel Norcross and Ben Jones are in Manchester. Support the show with a Nerd Pledge at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/thefinalword⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We're giving away a brand new Virat Kohli Genius King Cricket Bat, Gloves and Case PLUS a YEARS supply of Noobru Pro - worth over £1600! TO ENTER and full T&C's and 15% off go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠noobru.com/finalword⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We're giving away a brand new Virat Kohli Genius King Cricket Bat, Gloves and Case PLUS a YEARS supply of Noobru Pro - worth over £1600! TO ENTER and full T&C's, go to noobru.com/finalword Tickets for our Wormsley match, August 18: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠uk.emma-live.com/WormsleyFinal2025⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Subscribe to Wisden and never pay full price for the Almanack again: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.wisdenalmanack.com/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get your big NordVPN discount: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠nordvpn.com/tfw⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Maurice Blackburn Lawyers - fighting for the rights of workers since 1919: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠mauriceblackburn.com.au⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get 10% off Glenn Maxwell's sunnies: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠t20vision.com/FINALWORD⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Find previous episodes at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠finalwordcricket.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Title track by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Urthboy⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Text Courtesy: Rahul Foundation and Janchetna, Lucknow* Curated by Irfan* Narrated by Read Aloud Collective*Sound Design, Digital Enhancement and Production: Dr Guri*Co-ordination: Aditya Agnihotri and Naresh Kaushik*Administration: Saurav Nag*Featured Voices:00:00:01 Vibha Mahajan 00:07:25 Dr Guri00:10:20 Aditya Agnihotri00:15:32 Ruby Snita00:21:47 Pragya Mishra00:31:52 Satyarth Anirudh00:36:52 Madhu Bhandari00:41:18 Dr Guri00:44:32 Ati Ullah00:48:48 Monalisa Jha00:53:43 Sakshi Joshi00:58:24 Chetan Kate01:01:11 SZA Husain Shezi01:04:26 Ambica Sharma01:07:45 Minakshi01:09:58 Devraj Roshan01:11:06 Shraddha Singh01:13:55 Huma Askary01:17:01 Sanjay Kumar01:19:41 Monika01:22:54 Jyoti01:26:22 Shalini01:28:05 Kashan Mustafa01:32:37 Dr Guri01:37:21 Anurag Shrivastava01:46:52 Nishant01:48:49 PS (8452816818)01:52:32 Utkarsh Shukla01:56:11 Naresh Kaushik01:59:21 Tapik Jaipuria02:02:25 Pragya Mishra02:06:44 Deepti Deepu02:10:32 Aditya Agnihotri02:13:48 Pragati Pandey02:16:23 Chetan Kate02:21:39 Sakshi Joshi02:27:33 Mukesh Burnwal02:33:55 Madhu Bandari~End~Listen with Irfan (LwI)A tapestry of voices and stories, spun with careSupport LwI — a soulful creation shaped by affection, thriving on the warmth of its listeners. Your contribution helps keep this free, bringing global stories, rare sound recordings, and personal music archives to all without paywalls. I curate voices, readings from literature, and cultural studies with immense care.Through my recent initiative, Read Aloud Collective, voices from around the world are coming together in celebration of spoken word.Grateful for your love -keep listening, keep supporting!  Curator: IrfanSupport LwI by contributing:  https://rzp.io/rzp/MemorywalaYour comments and feedback are welcome. Write to ramrotiaaloo@gmail.com

Growing up around the hotel business, Amar Shah and Rahul Rohatgi never felt called to operate properties themselves. Instead, they felt compelled to tell the stories behind them—and how South Asians helped reshape the trajectory of the American hospitality industry. In this episode, Teague sits down with the directors of "The Patel Motel Story," a short-film making waves at the Tribeca Film Festival. For Amar, a self-described “counter kid” who grew up working at his family's gas station, the project is deeply personal. Rahul's path was different, but their shared roots and vision brought this story to life. The film is the result of years of research, interviews, and time spent at AAHOA conventions—piecing together a narrative that had never truly been told on screen. Together, they talk about heritage, the hustle behind the American Dream, and why the time was right to tell it now.

In this episode of The Oncology Brothers, Drs. Rahul and Rohit Gosain are joined by Dr. Anand Patel, a hematologist and Medical Director of Inpatient Leukemia Service at the University of Chicago. Together, they delved into the complexities of acute myeloid leukemia (AML), one of the most aggressive cancers encountered in clinical practice. Episode Highlights: • Understanding the current standard of care for AML, including diagnosis and risk stratification. • The importance of molecular profiling and how it influences treatment decisions. • A detailed discussion on induction chemotherapy options, including the classic 7+3 regimen and CPX351 for therapy-related AML. • Insights into the use of hypomethylating agents combined with venetoclax for patients unfit for intensive chemotherapy. • The role of targeted therapies in both upfront treatment and relapsed/refractory settings. • Key considerations for managing side effects, including cytopenias and infections. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ YouTube: https://youtu.be/gbgRbrjHxmQ Join us as we bridge the gap between academic research and community practice, providing valuable insights for healthcare professionals treating AML patients.  Don't forget to like, subscribe, and check out our other episodes for more discussions on challenging cases and treatment algorithms!

In this episode of Generative Now, Lightspeed Partner Michael Mignano sits down with Rahul Vohra, founder of the email client Superhuman, to unpack the future of AI-powered productivity. Rahul shares the origin story of Superhuman, how game design principles shaped its blazing speed and keyboard-first UX, and why time—not email—is the real problem it solves. He dives into the thinking behind their recent acquisition by Grammarly, his vision for an AI-native productivity suite, and what it means to build both apps and agents for the future. Episode Chapters00:00 Introduction and Guest Overview01:00 The Superhuman Email Experience02:28 Building Superhuman: Challenges and Innovations04:50 The Importance of Speed and Efficiency05:36 Superhuman's Unique Features and Early Decisions11:44 The Acquisition by Grammarly15:35 The Vision for an AI Native Productivity Suite22:32 Exploring Verticalized Workflows22:52 The Excitement of the Superhuman-Grammarly Deal24:23 The Strategy of Bundling28:10 AI's Role in Future Productivity32:26 Superhuman's Use of AI41:53 Lessons from Previous AcquisitionsStay in touch:www.lsvp.comX: https://twitter.com/lightspeedvpLinkedIn: https://www.linkedin.com/company/lightspeed-venture-partners/Instagram: https://www.instagram.com/lightspeedventurepartners/Subscribe on your favorite podcast app: generativenow.coEmail: generativenow@lsvp.comThe content here does not constitute tax, legal, business or investment advice or an offer to provide such advice, should not be construed as advocating the purchase or sale of any security or investment or a recommendation of any company, and is not an offer, or solicitation of an offer, for the purchase or sale of any security or investment product. The views expressed by our guests do not necessarily represent the views of Lightspeed. For more details please see lsvp.com/legal.

Welcome to this episode of The Oncology Brothers! Drs. Rahul and Rohit Gosain dived into the complexities of relapsed refractory diffuse large B-cell lymphoma (DLBCL) with their new series focused on challenging real-life cases. In this episode, we are joined by esteemed guests Dr. Carla Casulo from Wilmot Cancer Center and Dr. Tara Graff from Mission Cancer and Blood Center. Together, we explored the current standard of care, including R-CHOP and the role of bi-specific antibodies like epcoritamab and glofitimab. Key topics covered included: • When to use bi-specific antibodies and how to manage side effects • The importance of MRD monitoring in treatment decisions • Insights on patient management in community oncology settings • The evolving landscape of treatment options for DLBCL, including CAR-T therapy and clinical trials We also discuss practical considerations for community oncologists, including the management of cytokine release syndrome (CRS) and the role of immunoglobulin therapy in patients with low IgG levels. Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode is packed with valuable insights and expert opinions. YouTube: https://youtu.be/05ieIyAIx_8 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to like, subscribe, and share your thoughts in the comments! Let us know if there are specific scenarios you'd like us to cover in future episodes.

Send us a textHello and welcome everyone to The Cricket Slouch, a podcast where even though narrative rules, the numbers in context cannot be ignored. In this episode we will cover the 3rd test between England and India, and the 3rd test between Australia and West Indies. We talk about the efforts of Jadeja and Rahul, Green and Greaves, Seales and the Josephs, but more than that those of Stokes, Starc and Scotty Boland, India's continued woes with catching, why we can't let bye-gones be gone, and why Sundar might be the new Duckett.To make some sense of some of these crazy numbers, I am joined by Shounak and Ajit, who have both generously donated some of their precious time to this cause. .Have fun listening and spread the word !

Rahul moved to US for his Masters and after 11 years, he and his family moved back to India early in 2025. Rahul talks about his back ground, why he moved to India. He talks about how his wife was NOT onboarded with the move initially and what compromises they made to make this transition. He talks about growth opportunities in India and life in Tier2 city.

Tune in as actors Suresh Krishna, Saiju Kurup, and director Rahul Riji Nair join us on Club Studio to spill all about their latest film Flask. From behind-the-scenes fun to untold stories from the sets, this episode is packed with laughter, nostalgia, and plenty of film talk.#SaijuKurup #SureshKrishna #FlaskMovie #ClubFM

England 387 (Root 104, Carse 56, Smith 51; Bumrah 5-74) & 192 (Root 40; Sundar 4-22) India 387 (Rahul 100, Pant 74, Jadeja 72; Woakes 3-84) & 170 (Jadeja 61*; Stokes 3-48, Archer 3-55) England win by 22 runs and lead series 2-1 Where to begin with this tense final day of a compelling Third Test, in front of a full house at Lord's? Five days of drama ending with a ball trickling back on to stumps and dislodging a bail. Dan looks back at a day that will be talked about for years to come. Learn more about your ad choices. Visit podcastchoices.com/adchoices

England 387 (Root 104, Carse 56, Smith 51; Bumrah 5-74) & 192 (Root 40; Sundar 4-22) India 387 (Rahul 100, Pant 74, Jadeja 72; Woakes 3-84) & 58-4 (Rahul 33*, Carse 2-11) India need 135 runs to win What a day of Test cricket! This paragraph from the BBC's Stephan Shemilt sums it up perfectly Handbags on the third evening fuelled a pulsating fourth day. Much of the third Test had meandered and drifted, only for a super Sunday to set up a potentially manic Monday Toby was at Lord's and looks back on the day's play Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today's Episode is all about collaboration. To anyone in the London Market, VIPR has become a very well-known technology company, particularly in the area of Delegated Authority, where its Bordereaux management systems have achieved a critical mass of adoption. But as the business looks to expand globally, particularly the huge and strategically-crucial US market, it needs to partner with existing major players to achieve its goal. Just because we all know that weaning the insurance sector off spreadsheets and other documents is a universal problem, it doesn't follow that a business like VIPR will automatically gain business just because it has a solution that has been tried and tested over time. This is where Sikich comes in, as a trusted adviser implementing technological transformation, it's picked VIPR to go to market to help prepare itself for the coming fully-digital and AI-enabled age. In this podcast Rahul Bhatia, Principal at Sikich and Tony Russell Chief Revenue Officer at VIPR outline this alliance and the huge prize on offer to clients that are able to automate how data, not documents, flow through their businesses, from their customers and onto their own suppliers and wider stakeholders. MGAs, particularly US-domiciled ones, have ridden a spectacular wave of growth in the past decade. If that is to continue and they are to cement their tech advantage, they need to listen to what Rahul and Tony have to say. We live in exciting, revolutionary times and today VIPR and Sikich are at the frontier of delivering a lot of the technological change that much of the industry has been dreaming about for decades. So if you want to know how underwriters can grow without adding to cost while at the same time becoming more skilful at underwriting and more responsive to client needs and new demand, this podcast is for you. Rahul and Tony are hugely experienced in this field and are relatable, down to earth and easy to talk to. I can highly recommend a listen. LINKS & CONTACTS: https://www.viprsolutions.com/ www.sikich.com Rahul Bhatia's contacts are: LinkedIn https://www.linkedin.com/in/rahul-bhatia-profile/ Email rahul.bhatia@sikich.com

In this episode of the Oncology Brothers podcast, Drs. Rahul and Rohit Gosain are joined by Dr. Deepa Rangachari, a thoracic medical oncologist and fellowship program director at Beth Israel Deaconess Medical Center. Together, they dived deep into the treatment algorithms for early-stage non-small cell lung cancer (NSCLC) with a focus on curative intent. Key topics discussed include: •⁠  ⁠The importance of staging and lymph node evaluation in treatment planning. •⁠  ⁠The role of neoadjuvant chemoimmunotherapy and the impact of recent trial data, including the CHECKMATE 816 trial. •⁠  ⁠The significance of actionable mutations and the use of targeted therapies like Osimertinib and Alectinib. •⁠  ⁠The evolving role of ctDNA in treatment decisions and monitoring. •⁠  ⁠Insights into the management of side effects associated with Osimertinib and Alectinib. •⁠  ⁠The standard of care for unresectable stage 3 NSCLC, including concurrent chemoradiation and the use of Durvalumab. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Join us for an informative discussion that highlights the latest advancements in lung cancer treatment and the importance of personalized care. Don't forget to check out our other episodes in the lung cancer treatment algorithm series!

Political Storm in India | Fadnavis Traps Anti-Hindi Alliance | Rahul's Surrender before Tejaswi

Fluent Fiction - Hindi: Journey to Inner Peace: Rahul's Retreat Revelation Find the full episode transcript, vocabulary words, and more:fluentfiction.com/hi/episode/2025-07-09-22-34-02-hi Story Transcript:Hi: गर्मियों की एक सुबह थी।En: It was a summer morning.Hi: सूरज की किरणें हरियाली से ढके पर्वतों को चमकदार बना रही थीं।En: The rays of the sun were making the mountains covered in greenery shine brightly.Hi: उन पर्वतों के बीच में एक आध्यात्मिक रिट्रीट था।En: Among those mountains, there was a spiritual retreat.Hi: रिट्रीट का वातावरण शांति और सुकून से भरा हुआ था।En: The atmosphere at the retreat was filled with peace and serenity.Hi: यहाँ आने वाला हर व्यक्ति अपने भीतर की शांति खोजने आया था।En: Everyone who came here did so to find peace within themselves.Hi: राहुल, एक कॉर्पोरेट पेशेवर, भी यहाँ आया था।En: Rahul, a corporate professional, had also come here.Hi: उसकी ज़िंदगी अधिकतर समय काम में व्यस्त रहती थी और उसे अपने आध्यात्मिक पक्ष से जुड़े रहना मुश्किल लगता था।En: His life was mostly busy with work, and he found it difficult to stay connected with his spiritual side.Hi: राहुल को खुद के लिए समय चाहिए था।En: Rahul needed some time for himself.Hi: इसलिए उसने तय किया कि वह अपने ऑफिस के काम से कुछ समय की छुट्टी लेकर इस रिट्रीट में भाग लेगा।En: So he decided to take a break from his office work and participate in this retreat.Hi: राहुल के साथ उसकी मित्र मीरा और अंजली भी थीं।En: With Rahul were his friends Meera and Anjali.Hi: उन्होंने सोचा, रिट्रीट के दौरान उन्हें ध्यान के लिए कुछ चीज़ें खरीदनी चाहिए।En: They thought they should buy some items for meditation during the retreat.Hi: वे तीनों रिट्रीट के ध्यान सामान की दुकान में पहुंचे।En: The three of them arrived at the retreat's meditation supplies store.Hi: दुकान चारों ओर से लम्बे और हरे-भरे पेड़ों से घिरी हुई थी।En: The shop was surrounded by tall, lush green trees.Hi: वहां की शांति और खूबसूरती ने सभी को मोहित कर दिया।En: The peace and beauty of the place captivated everyone.Hi: दुकान में प्रवेश करते ही, राहुल की नज़र एक सादे ध्यान के आसन पर पड़ी।En: As soon as they entered the shop, Rahul noticed a simple meditation mat.Hi: उसे केवल ध्यान और आंतरिक शांति चाहिए थी।En: He only wanted meditation and inner peace.Hi: पर तभी उसकी नज़र एक महंगे और आकर्षक ध्यान के आसन पर भी पड़ी।En: But then his eyes fell on an expensive and attractive meditation mat.Hi: यह निर्णय राहुल के लिए कठिन था।En: This decision was difficult for Rahul.Hi: एक ओर साधारणता थी, तो दूसरी ओर भव्यता और मोहकता।En: On one side, there was simplicity, and on the other, grandeur and allure.Hi: राहुल कुछ समय के लिए उलझन में था।En: Rahul was confused for a while.Hi: लेकिन उसने खुद से कहा, "सच्ची शांति अपने भीतर होती है, न कि बाहरी वस्तुओं में।En: But he told himself, "True peace lies within, not in external objects."Hi: " यह सोचते हुए, उसने साधारण आसन खरीदने का निर्णय लिया।En: Thinking this, he decided to buy the simple mat.Hi: दुकान से बाहर आते वक्त, उसने महसूस किया कि उसका मन अब पहले से अधिक शांत था।En: While coming out of the shop, he felt that his mind was now calmer than before.Hi: यह एक छोटा किन्तु महत्वपूर्ण बदलाव था।En: It was a small but significant change.Hi: उसने यह जाना कि बाहरी चीजें भले ही सुंदर दिखें, पर असली सुंदरता और शांति तो मन की होती है।En: He learned that external things might look beautiful, but the true beauty and peace lie within the mind.Hi: इस अनुभव ने राहुल को संतुलित बनना सिखाया और वह जान गया कि आंतरिक सुख और शांति के लिए जरूरी है कि हम अपने जीवन में एक सही संतुलन बनाएं।En: This experience taught Rahul to become balanced and he understood that for inner happiness and peace, it is essential to maintain the right balance in life.Hi: इस रिट्रीट ने उसकी सोच और जीवन को एक नई दिशा दी।En: This retreat gave his thinking and life a new direction.Hi: राहुल अब जब भी अपने काम में व्यस्त हो जाता, वह इस अनुभव को याद करता और तुरंत ही खुद को बेहतर महसूस कराता।En: Now, whenever Rahul became busy with work, he would remember this experience and immediately feel better.Hi: क्योंकि अब वह जान चुका था कि असली सुख की चाबी हमारे भीतर होती है।En: Because he now knew that the key to true happiness lies within us. Vocabulary Words:rays: किरणेंspiritual: आध्यात्मिकretreat: रिट्रीटserenity: सुकूनparticipate: भाग लेनाcorporate: कॉर्पोरेटsupplies: सामानlush: हरे-भरेcaptivated: मोहितmat: आसनsimplicity: साधारणताgrandeur: भव्यताallure: मोहकताdecision: निर्णयconfused: उलझनsignificant: महत्वपूर्णexternal: बाहरीinternal: आंतरिकbalance: संतुलनbeauty: सुंदरताdirection: दिशाhappiness: सुखnecessary: जरूरीexperience: अनुभवcalmer: शांतpurchase: खरीदनाconnected: जुड़ेsurrounded: घिरीshine: चमकदारtemptation: प्रलोभन

How a €1 B digital‑engineering firm uses generative AI and agent tech to reinvent retail supply chains and CX.18 000 engineers, €1 B revenue, 50+ patents—Nagarro's Global CTO Rahul Mahajan explains how generative AI, vector databases and knowledge graphs are reshaping demand planning and personalization at scale.⏱️ CHAPTERS00:00 Intro: product‑to‑service mind‑set 00:22 Meet Rahul Mahajan & Nagarro overview 01:17 Missed NRF meetings + digital engineering culture 02:35 Diversified industries & complex problem solving 03:35 Rahul's 50+ patents in retail AI 04:58 CPG use case: multi‑channel demand planning 06:49 SKU‑level AI forecasting & supply chain accuracy 07:32 “Humanizing personalization” patent explained 08:20 Ecosystem shift: partner products & services 09:29 Agent tech & zero‑downtime integration 10:16 From transactions to lifestyle services 12:08 Patenting novel data structures & AI models 13:19 Knowledge graphs + vectorized semantics 14:24 AI governance: tone, privacy, explainability 15:14 LLM interoperability (OpenAI, Anthropic, Gemini) 16:32 Why retailers must move before they're disrupted 17:13 Contact Rahul & closing

Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain, both practicing community oncologists, are joined by Dr. Tian Zhang from UT Southwestern to discuss key highlights from the ASCO 2025 annual meeting, focusing on genitourinary (GU) malignancies. Episode Highlights: • KEYNOTE-564: discussed 5 years OS data, reinforcing the role of adjuvant pembrolizumab in renal cell carcinoma • AMPLITUDE: combination of PARP inhibitor niraparib with abiraterone improved progression-free survival in patients with homologous recombination repair mutations in metastatic hormone-sensitive prostate cancer • ARANOTE: positive quality of life impact when using darolutamide in metastatic hormone-sensitive prostate cancer, which is also FDA approved now • NIAGARA: the prognostic value of ctDNA in muscle-invasive bladder cancer, emphasizing its implications for treatment strategies YouTube: https://youtu.be/Rt8HQpdyVY0 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Join us as we break down these important studies and their potential to change clinical practice in oncology. Don't forget to check out our other episodes for more insights into cancer care!

Attack on Yogi, T Raja Singh's exit, Kejriwal's Punjab dreams & Rahul's Congress crisis, Harsh Kumar joins Sanjay Dixit to decode BJP's caste bets in UP, Delhi's bulldozers & Punjab's AAP surge.

Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Ross Camidge, a leading thoracic medical oncologist from the University of Colorado, to discuss the recent approval of telisotuzumab-vedotin (Teliso-V) for metastatic non-small cell lung cancer (NSCLC) with C-met overexpression, based on the LUMINOSITY trial. Join us as we explore: • The mechanism of action of telisotuzumab and its role as an antibody-drug conjugate. • The prevalence of C-met overexpression in NSCLC and its implications for testing and treatment. • Key findings from the Luminosity trial, including response rates and study design. • The importance of C-met testing in clinical practice. • Management of side effects associated with telisotuzumab, particularly peripheral neuropathy. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ This episode is packed with valuable insights for oncologists and healthcare professionals navigating the evolving landscape of lung cancer treatment. Don't miss out on this informative discussion!

AI without a data science team? It's not a fantasy it's the future.In this week's SaaS Fuel episode, Jeff Mains sits down with Rahul Pangam, CEO of RapidCanvas and former VP at PayPal, to explore how AI is becoming accessible to every SaaS founder no code required.We dive deep into the enterprise AI dilemma: where to start, what ROI to expect, and how to avoid wasting budget on hype. Rahul shares how RapidCanvas is transforming messy, unstructured data into real-time insights for non-technical users, and the hard-earned startup lessons that shaped this vision.If you're sitting on data gold but don't know how to mine it, this episode is your blueprint for action.Key Takeaways00:00 - The AI dilemma: start now or risk falling behind?01:09 - Welcome to SaaS Fuel01:38 - What if you could build AI without writing code?02:28 - AI is being democratized—finally03:15 - Recap: Patricia Fripp & Andrew Seidman episodes04:03 - Meet Rahul Pangam of RapidCanvas05:05 - From PayPal to RapidCanvas: Rahul's journey10:59 - What problem does RapidCanvas solve?16:27 - Pairing digital intelligence with domain expertise19:18 - Why outcomes—not code—drive AI adoption20:35 - Is AI only for big tech? How it's being democratized23:58 - Turning PDFs into insight without tech skills25:48 - Hard lessons from Rahul's first startup28:52 - From startup to PayPal: what corporate taught him33:58 - Hiring & product mistakes that left a mark37:39 - Scaling stage: can everyone grow with the company?39:09 - How to build trust in skeptical buyers44:21 - Should AI be on your roadmap? Ask this question47:01 - Where does AI fit in your org?50:14 - Where to find Rahul & RapidCanvas online51:55 - Cupcakes, Series A sprinkles & future guestsTweetable Quotes“If you don't do AI, your board asks why. If you do, you wonder where to even start.” — Rahul Pangam“You don't need a data science degree to use AI—you need the right platform.” — Jeff Mains“AI isn't about writing code. It's about delivering outcomes.” — Rahul Pangam“Stop chasing trends. Start solving real problems with real data.” — Jeff Mains“The most valuable startups don't build tools—they deliver results.” — Rahul Pangam“Data alone isn't an asset until you can act on it.” — Jeff MainsSaaS Leadership LessonsYou don't need a data team to implement AI.Natural language platforms like RapidCanvas are bridging the tech gap.Most leaders don't lack data—they lack clarity.Turning information into insight is where real transformation starts.AI adoption must be outcome-driven.Focus on business impact, not fancy features or buzzwords.Founders must guide AI from concept to outcome.Even no-code tools need leadership to shape direction and alignment.Startup scars shape smart strategy.Rahul's lessons from Simility highlight the value of postmortem reflection and iteration.AI implementation isn't about automation—it's about acceleration.It's not about replacing people. It's about empowering decision-makers faster.Guest ResourcesEmail - rahul@rapidcanvas.aiWebsite - http://rapidcanvas.ai/LinkedIn - https://www.linkedin.com/in/rahulpangam/Episode...

Industrial Talk is onsite at Hexagon LIVE and talking to Kyle Wessells, Rahul Shinde, Ryan McOdrum and Matthew Peak at Hexagon ALI about "Game changing asset management platform". Scott MacKenzie hosts the Industrial Talk podcast, featuring discussions on industry innovations and trends. At Hexagon Live in Las Vegas, MacKenzie highlights the Asset Life Cycle Intelligence (ALI) platform and Asset Performance Management (APM) solutions. ALI integrates smart 3D design with SDx2 for continuous data synchronization, enhancing asset management. Hexagon EAM, a configurable system for enterprise asset management, supports compliance across various industries. APM uses machine learning to predict asset health and integrate sensor data, aiding in proactive maintenance. The conversation emphasizes the importance of data continuity and the role of AI in improving operational efficiency. Action Items [ ] Reach out to Rahul Shinde (Senior Solutions Consultant at Hexagon) on LinkedIn or at rahul.shinde@hexagon.com to learn more about the integration of 3D design tools and STX2. [ ] Connect with Ryan McOdrum (Sr. Solutions Consultant at Hexagon) on LinkedIn or at ryan.mcodrum@hexagon.com to discuss Hexagon EAM and its configurability. [ ] Follow up with Matt Peak (Solution Consultant at Hexagon) on LinkedIn or at matt.peak@hexagon.com to understand the integration of Hexagon EAM, APM, and J5 Operations Management. Outline Hexagon Live Event Overview Scott MacKenzie introduces the Industrial Talk Podcast and its focus on industry innovations and trends. Scott MacKenzie recaps the Hexagon Live event in Las Vegas, highlighting the innovations and solutions showcased. Scott MacKenzie mentions the Asset Life Cycle Intelligence Platform (ALI) from Hexagon and its significance. Scott MacKenzie promotes an ebook and a workbook available for free download on the Industrial Talk website. Introduction to ALI and APM Scott MacKenzie discusses the importance of ALI and APM (Asset Performance Management) in providing greater insights into assets and business operations. Scott MacKenzie introduces Kyle and mentions the interactive art gallery at Hexagon Live. Kyle explains the interactive art gallery's purpose in representing visibility and value drivers. Kyle introduces the smart 3D design solution and its integration with SDx2, emphasizing data synchronization and contextualization. Smart 3D and SDx2 Integration Rahul explains the integration of smart 3D and SDx2, including data synchronization from P&IDs and 3D models. Scott MacKenzie inquires about the digitization of P&IDs and the use of legacy data. Rahul details the process of digitizing P&IDs and synchronizing data to SDx2 for better management and maintenance. Rahul highlights the business rationale behind the integration, including the use of design tools for maintenance and operations. Business Rationale and Implementation Rahul explains the business rationale for using design tools in maintenance and operations, enhancing sustainability. Scott MacKenzie asks about the journey to achieving a common record for accurate data management. Rahul outlines the infrastructure requirements for connecting design solutions to SDx2 and the benefits of a secure, scalable solution....

Abhishek Tiwari joins Sanjay Dixit to decode Modi's triple-front assault: geopolitical dominance, Bihar battlefield, and internal BJP resets. Rahul stumbles, opposition cracks, while Modi's East push and Shah–Yogi pact redraw the game.

Actor, activist, and passionate rugby advocate Rahul Bose joins Cyrus for an energetic and engaging episode of Cyrus Says. The two dive into a spirited conversation about the newly launched Rugby Premier League, with Rahul breaking down its vision, structure, and why he believes India — and specifically Mumbai — is the perfect ground to kick off this sporting revolution. Beyond the game, the episode is packed with laughs as Rahul and Cyrus explore the art of accents, perform impromptu impressions, and riff off each other’s wit. Equal parts informative and entertaining, this episode is a treat for sports lovers, rugby newbies, and long-time fans of Cyrus' trademark chaos.See omnystudio.com/listener for privacy information.

Welcome to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Erika Hamilton from the Sarah Cannon Research Institute to discuss the latest breakthroughs in breast cancer presented at the ASCO 2025 annual meeting. We dived into five key abstracts that could change the landscape of breast cancer treatment: 1.⁠ INAVO120: observed overall survival data with the combination of inavolisib, with palbociclib and fulvestrant for patients with PIK3CA mutated hormone receptor-positive, HER2-negative advanced breast cancer. 2.⁠ ⁠SERENA-6: camizestrant use in patients with emerging ESR1 mutations using ctDNA, showed significant improvement in progression-free survival. 3.⁠ ⁠VERITAC-2: vepdegestrant showed superior progression-free survival compared to fulvestrant, particularly in ESR1 mutated patients. 4.⁠ ⁠DESTINY-Breast09: significant improvement in progression-free survival with TDXd plus pertuzumab in frontline HER2-positive metastatic breast cancer, challenging the traditional CLEOPATRA regimen THP. 5.⁠ ⁠ASCENT-04: promising results of sacituzumab combined with pembrolizumab in PD-L1 positive triple-negative breast cancer. Join us for an insightful discussion on these practice changing/informing studies and their implications for clinical practice.  YouTube: https://youtu.be/5XvrOn2p0jc Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to like, subscribe, and check out our other episodes for more updates on treatment algorithms, recent approvals, and conference highlights!

This week, host Avdhesh Kumar is joined by Newslaundry's Sumedha Mittal, BBC's Abhinav Goel and reporter Akansha Kumar. Abhinav presents an in-depth report on the true death toll of the Mahakumbh Mela tragedy that happened in January. While the Uttar Pradesh government has officially acknowledged 37 deaths due to the stampede, BBC's investigation has uncovered at least 82 fatalities so far. Despite government promises, many of the victims' families have yet to receive the promised compensation.Akansha uncovers allegations of police impunity in Kaushambi in Uttar Pradesh. Her deep dive into police encounters in Uttar Pradesh reveal chilling accounts from families who lost loved ones in suspected extrajudicial killings.Several families allege that police not only carried out unlawful encounters but also attempted to silence them with bribes. Many of these encounters took place in the same location: Goonghwa Ka Bagh in Kaushambi. Affected families are running from pillar to post in their fight for justice and accountability.Meanwhile, Sumedha brings a sharply different story from Delhi. Since his appointment as Lieutenant Governor in May 2022, VK Saxena was known for publicly targeting the AAP-led government over civic issues. However, his stance appears to have softened following the BJP's rise to power in February 2025.Sumedha's report explores this shift in tone – tracing how the LG's confrontational approach has evolved and what it reveals about the changing political dynamics in the capital.Timecodes00:00:00 - Introduction00:01:04 - Beyond 82: The Controversy Over Kumbh Stampede Casualties00:31:20 - Encounter Raj in UP: A Deep Dive into Its Persistent Reality00:52:24 - Dynamics Between Delhi's LG and the Ruling Party: An observer's view00:59: 58 - RecommendationsRecommendationsAbhinavThe Unwomanly Face of WarThe Sharp Knife of MemorySumedha Rahul Gandhi writes: Match-fixing MaharashtraToday in Politics: Congress to make people aware of Rahul's ‘fixing polls claims' with processions across MaharashtraAkansha Among the Trolls: My Journey Through ConspiracylandAvdheshDr. Ambedkar: Life And MissionProduced and edited by Hassan Bilal and Tista Roy Chowdhury, recorded by Anil Kumar. Hosted on Acast. See acast.com/privacy for more information.

Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Cathy Eng, a renowned GI medical oncologist from the Vanderbilt Ingram Cancer Center, to discuss the most impactful updates from the ASCO 2025 annual meeting, specifically focusing on gastrointestinal (GI) malignancies. Join us as we dive into five pivotal abstracts that are set to change the landscape of GI cancer treatment: 1.⁠ ⁠DYNAMIC III: Discover how ctDNA-guided adjuvant chemotherapy in stage 3 colon cancer did not improve outcomes, highlighting questionable role of escalating approach with ctDNA positivity. 2.⁠ ⁠ATOMIC: Learn about the addition of atezolizumab to FOLFIRI in MSI-H disease stage 3 colon cancer, which improved disease-free survival with a hazard ratio of 0.50. 3.⁠ ⁠BREAKWATER: Explore how the combination of encorafenib, cetuximab, and FOLFOX has established a new standard of care for BRAF V600E mutant metastatic colorectal cancer, doubling overall survival from 15 months to 30.3 months. 4.⁠ ⁠MATTERHORN: Understand the use of durvalumab in the perioperative and postoperative setting with the FLOT regimen for resectable gastric and GE junction adenocarcinoma, showing significant improvements in event-free survival. 5.⁠ ⁠DESTINY Gastric04: Delved into the findings that confirm TDXd as a preferred option in the second line and beyond for HER2 positive metastatic gastric cancer or GE junction adenocarcinoma. YouTube: https://youtu.be/hllyI5S2Dqg Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Tune in for an insightful discussion that will keep you updated on the latest advancements in GI oncology! Don't forget to subscribe for more episodes on treatment algorithms, FDA approvals, and conference highlights.

What does it take to drive product innovation in industries that aren't traditionally product-led?Heather Samarin and Vidya Dinamani sit down with Rahul Nath, CPO at Accel, who brings rich experience from Google, Drip Capital, and McKinsey. Rahul shares how he builds product in non-product-led spaces, from redefining onboarding in trade finance to leveraging AI in venture capital. Hear Rahul's practical lessons on stakeholder alignment, scrappy experimentation, data-driven decision-making, and why he believes “if there's no clear strategy—write one.” A must-listen for product leaders navigating ambiguity and driving bold transformation.

WE APPRECIATE EACH AND EVERY ONE OF YOU! If you wouldn't mind please go leave us a review on Apple Podcasts! Thanks!!Welcome back to Episode 359 of On the Spot Sports and in today's episode we have a very special guest, Danbury Hat Tricks goaltender, Rahul Sharma! Rahul and I talk about his first year of professional hockey in the FPHL. We also talk about the process of going from practice goalie to starting games, falling in love with the process, having faith and belief in what you do, growth as a person and athlete, finding ways to get better every day, Junior hockey and continuing to push greatness despite slow starts, coming back to hockey after an injury and so much more! We hope you guys enjoy this episode!!Thank you Rahul for coming on the show! I had a blast!!Follow us on Instagram @on_the_spot_sports and take a listen on YouTube, Spotify and Apple/Google Podcasts @ On The Spot SportsGet $25 off our guy Jamie Phillips Nutrition book for Hockey Players with the discount code "ONTHESPOT" on victoremnutrition.comLiving Sisu link: ⁠⁠https://livingsisu.com/app/devenirmem.... BECOME A MEMBER TODAY

Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Stephen Liu from Georgetown Lombardi Comprehensive Cancer Center to discuss the latest and most impactful findings from the ASCO 2025 meeting, focusing on lung cancer. Join us as we dive into five key studies that could change clinical practice: 1. CheckMate 816: Discover the significant overall survival benefits of neoadjuvant chemotherapy combined with nivolumab in resectable non-small cell lung cancer. 2. Timing of Immunotherapy: Explore a groundbreaking study that reveals how the timing of immunotherapy infusions can dramatically affect patient outcomes. 3. NeoADAURA Trial: Learn about the use of osimertinib in the neoadjuvant setting for EGFR-mutated lung cancer and how it compares to established adjuvant therapies. 4. IMforte Study: Understand the implications of maintenance therapy in small cell lung cancer and how it can improve overall survival rates. 5. DeLLphi 304: Get insights into the efficacy of tarlatamab as a second-line treatment for small cell lung cancer and its potential to become the new standard of care. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Tune in for an engaging discussion filled with expert insights, clinical pearls, and the latest advancements in lung cancer treatment. Don't forget to like, subscribe, and check out our other conference highlights! #OncologyBrothers #LungCancer #ASCO2025 #CancerResearch #Immunotherapy #EGFR #SmallCellLungCancer #NeoadjuvantTherapy #Podcast

Our guests are Rahul Saito and Mitsu Nagae.  Rahul is the owner and Mitsu is the co-owner and executive chef at l'abeille https://www.labeille.nyc and l'abeille à côté https://www.labeilleacote.nyc/ in Tribeca, New York. The duo opened l'abeille in March 2022 and shortly after, they won a Michelin star, thanks to Mitsu's unique and outstanding culinary background as a Japanese chef classically trained in Paris, Tokyo and New York as well as Rahul's sound management despite being new to the industry. Mitsu's menus are characterized by a seamless merge of French and Japanese cuisines, which seems to have become a relevant genre in places like Paris and Japan as well. In this episode, we will discuss how Mitsu got into French cuisine from a young age in Japan and eventually trained under top chefs like the late Joel Robuchon, why the seemingly opposite French and Japanese cuisines can go so well together as you can see in Mitsu's menus, the keys to run successful restaurants in New York and much, much more!!!

Rahul Jandial, MD, PhD, is a dual-trained brain surgeon and neuroscientist at City of Hope in Los Angeles, California. Before finding his calling in the operating room, Dr. Jandial was a college dropout and worked as a security guard. As a surgeon, he now provides complex surgical treatment to patients with cancer. As a scientist, his laboratory investigates the biology of the human brain. Throughout his career, he has authored 10 books and over 100 academic articles.Take action and strengthen your mind with The Resilient Mind Journal. Get your free digital copy today: ⁠⁠⁠⁠⁠https://bit.ly/Download_JournalSpecial thanks to Lewis Howes, subscribe to his channel here: https://www.youtube.com/c/lewishowesWatch the full interview on Lewis's page: https://www.youtube.com/watch?v=JYalx8bvEyg Hosted on Acast. See acast.com/privacy for more information.